Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability.

Giuffrida P, Arpa G, Grillo F, Klersy C, Sampietro G, Ardizzone S, Fociani P, Fiocca R, Latella G, Sessa F, D'Errico A, Malvi D, Mescoli C, Rugge M, Nesi G, Ferrero S, Furlan D, Poggioli G, Rizzello F, Macciomei MC, Santini D, Volta U, De Giorgio R, Caio G, Calabrò A, Ciacci C, D'Armiento M, Rizzo A, Solina G, Martino M, Tonelli F, Villanacci V, Cannizzaro R, Canzonieri V, Florena AM, Biancone L, Monteleone G, Caronna R, Ciardi A, Elli L, Caprioli F, Vecchi M, D'Incà R, Zingone F, D'Odorico A, Vincenzo Lenti M, Oreggia B, Reggiani Bonetti L, Astegiano M, Biletta E, Cantoro L, Giannone AG, Orlandi A, Papi C, Perfetti V, Quaquarini E, Sandri G, Silano M, Usai P, Barresi V, Ciccocioppo R, Luinetti O, Pedrazzoli P, Pietrabissa A, Viglio A, Paulli M, Corazza GR, Solcia E, Vanoli A, Di Sabatino A.

Mod Pathol. 2020 Feb 17. doi: 10.1038/s41379-020-0497-0. [Epub ahead of print]

PMID:
32066859
2.

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues.

Pusceddu S, Vernieri C, Di Maio M, Marconcini R, Spada F, Massironi S, Ibrahim T, Brizzi MP, Campana D, Faggiano A, Giuffrida D, Rinzivillo M, Cingarlini S, Aroldi F, Antonuzzo L, Berardi R, Catena L, De Divitiis C, Ermacora P, Perfetti V, Fontana A, Razzore P, Carnaghi C, Davì MV, Cauchi C, Duro M, Ricci S, Fazio N, Cavalcoli F, Bongiovanni A, La Salvia A, Brighi N, Colao A, Puliafito I, Panzuto F, Ortolani S, Zaniboni A, Di Costanzo F, Torniai M, Bajetta E, Tafuto S, Garattini SK, Femia D, Prinzi N, Concas L, Lo Russo G, Milione M, Giacomelli L, Buzzoni R, Delle Fave G, Mazzaferro V, de Braud F.

Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.

PMID:
29655834
3.

Molecular and functional characterization of a new 3' end KIT juxtamembrane deletion in a duodenal GIST treated with neoadjuvant Imatinib.

Perfetti V, Laurini E, Aulić S, Fermeglia M, Riboni R, Lucioni M, Dallera E, Delfanti S, Pugliese L, Latteri FS, Pietrabissa A, Pricl S.

Oncotarget. 2017 Jul 18;8(34):56158-56167. doi: 10.18632/oncotarget.19341. eCollection 2017 Aug 22.

4.

Small Bowel Carcinomas in Coeliac or Crohn's Disease: Clinico-pathological, Molecular, and Prognostic Features. A Study From the Small Bowel Cancer Italian Consortium.

Vanoli A, Di Sabatino A, Furlan D, Klersy C, Grillo F, Fiocca R, Mescoli C, Rugge M, Nesi G, Fociani P, Sampietro G, Ardizzone S, Luinetti O, Calabrò A, Tonelli F, Volta U, Santini D, Caio G, Giuffrida P, Elli L, Ferrero S, Latella G, Ciardi A, Caronna R, Solina G, Rizzo A, Ciacci C, D'Armiento FP, Salemme M, Villanacci V, Cannizzaro R, Canzonieri V, Reggiani Bonetti L, Biancone L, Monteleone G, Orlandi A, Santeusanio G, Macciomei MC, D'Incà R, Perfetti V, Sandri G, Silano M, Florena AM, Giannone AG, Papi C, Coppola L, Usai P, Maccioni A, Astegiano M, Migliora P, Manca R, Martino M, Trapani D, Cerutti R, Alberizzi P, Riboni R, Sessa F, Paulli M, Solcia E, Corazza GR.

J Crohns Colitis. 2017 Aug 1;11(8):942-953. doi: 10.1093/ecco-jcc/jjx031.

PMID:
28333239
5.

Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial Damage.

Diomede L, Romeo M, Rognoni P, Beeg M, Foray C, Ghibaudi E, Palladini G, Cherny RA, Verga L, Capello GL, Perfetti V, Fiordaliso F, Merlini G, Salmona M.

Antioxid Redox Signal. 2017 Sep 20;27(9):567-582. doi: 10.1089/ars.2016.6848. Epub 2017 Mar 3.

6.

Detection of Active Epstein-Barr Virus Infection in Duodenal Mucosa of Patients With Refractory Celiac Disease.

Perfetti V, Baldanti F, Lenti MV, Vanoli A, Biagi F, Gatti M, Riboni R, Dallera E, Paulli M, Pedrazzoli P, Corazza GR.

Clin Gastroenterol Hepatol. 2016 Aug;14(8):1216-20. doi: 10.1016/j.cgh.2016.03.022. Epub 2016 Mar 24.

PMID:
27033429
7.

Peritonitis secondary to spontaneous perforation of a primary gastrointestinal stromal tumour of the small intestine: A case report and a literature review.

Alessiani M, Gianola M, Rossi S, Perfetti V, Serra P, Zelaschi D, Magnani E, Cobianchi L.

Int J Surg Case Rep. 2015;6C:58-62. doi: 10.1016/j.ijscr.2014.12.012. Epub 2014 Dec 12.

8.

Investigating heart-specific toxicity of amyloidogenic immunoglobulin light chains: A lesson from C. elegans.

Diomede L, Rognoni P, Lavatelli F, Romeo M, di Fonzo A, Foray C, Fiordaliso F, Palladini G, Valentini V, Perfetti V, Salmona M, Merlini G.

Worm. 2014 Oct 30;3(3):e965590. doi: 10.4161/21624046.2014.965590. eCollection 2014 Jul-Sep.

9.

Systematic analysis of human oncogenic viruses in colon cancer revealed EBV latency in lymphoid infiltrates.

Fiorina L, Ricotti M, Vanoli A, Luinetti O, Dallera E, Riboni R, Paolucci S, Brugnatelli S, Paulli M, Pedrazzoli P, Baldanti F, Perfetti V.

Infect Agent Cancer. 2014 Jun 3;9:18. doi: 10.1186/1750-9378-9-18. eCollection 2014.

10.

A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis.

Diomede L, Rognoni P, Lavatelli F, Romeo M, del Favero E, Cantù L, Ghibaudi E, di Fonzo A, Corbelli A, Fiordaliso F, Palladini G, Valentini V, Perfetti V, Salmona M, Merlini G.

Blood. 2014 Jun 5;123(23):3543-52. doi: 10.1182/blood-2013-10-525634. Epub 2014 Mar 24.

11.

A strategy for synthesis of pathogenic human immunoglobulin free light chains in E. coli.

Rognoni P, Lavatelli F, Casarini S, Palladini G, Verga L, Pedrazzoli P, Valentini G, Merlini G, Perfetti V.

PLoS One. 2013 Sep 27;8(9):e76022. doi: 10.1371/journal.pone.0076022. eCollection 2013.

12.

Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome.

Perfetti V, Palladini G, De Amici M, Livraghi L, Pedrazzoli P, Merlini G.

Ann Hematol. 2013 Aug;92(8):1133-4. doi: 10.1007/s00277-013-1673-9. Epub 2013 Jan 19. No abstract available.

PMID:
23334107
13.

An overview of viral oncology in Italy - report from the Pavia meeting on solid tumors.

Perfetti V, Ricotti M, Buonaguro F, Tirelli U, Pedrazzoli P.

Infect Agent Cancer. 2012 Sep 5;7(1):23. doi: 10.1186/1750-9378-7-23.

14.

TCRβ clonality improves diagnostic yield of TCRγ clonality in refractory celiac disease.

Perfetti V, Brunetti L, Biagi F, Ciccocioppo R, Bianchi PI, Corazza GR.

J Clin Gastroenterol. 2012 Sep;46(8):675-9. doi: 10.1097/MCG.0b013e31823eff20.

PMID:
22298086
15.

The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44.

Perfetti V, Palladini G, Casarini S, Navazza V, Rognoni P, Obici L, Invernizzi R, Perlini S, Klersy C, Merlini G.

Blood. 2012 Jan 5;119(1):144-50. doi: 10.1182/blood-2011-05-355784. Epub 2011 Nov 8.

PMID:
22067386
16.

A metachronous splenic metastases from esophageal cancer: a case report.

Botrugno I, Jemos V, Cobianchi L, Fiandrino G, Brugnatelli S, Perfetti V, Vercelli A, Maestri M, Dionigi P.

World J Surg Oncol. 2011 Sep 16;9:105. doi: 10.1186/1477-7819-9-105.

17.

Liver involvement as the hallmark of aggressive disease in light chain amyloidosis: distinctive clinical features and role of light chain type in 225 patients.

Russo P, Palladini G, Foli A, Zenone Bragotti L, Milani P, Nuvolone M, Obici L, Perfetti V, Brugnatelli S, Invernizzi R, Merlini G.

Amyloid. 2011 Jun;18 Suppl 1:92-3. doi: 10.3109/13506129.2011.574354033. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:93.

PMID:
21838445
18.

Mass spectrometry-based proteomics as a diagnostic tool when immunoelectron microscopy fails in typing amyloid deposits.

Lavatelli F, Valentini V, Palladini G, Verga L, Russo P, Foli A, Obici L, Sarais G, Perfetti V, Casarini S, Merlini G.

Amyloid. 2011 Jun;18 Suppl 1:64-6. doi: 10.3109/13506129.2011.574354023. No abstract available. Erratum in: Amyloid. 2011 Jun;18 Suppl 1:66.

PMID:
21838435
19.

Immunotherapeutic Intervention against Sarcomas.

Pedrazzoli P, Secondino S, Perfetti V, Comoli P, Montagna D.

J Cancer. 2011;2:350-6. Epub 2011 Jun 13.

20.

A novel approach for the purification and proteomic analysis of pathogenic immunoglobulin free light chains from serum.

Lavatelli F, Brambilla F, Valentini V, Rognoni P, Casarini S, Di Silvestre D, Perfetti V, Palladini G, Sarais G, Mauri P, Merlini G.

Biochim Biophys Acta. 2011 Mar;1814(3):409-19. doi: 10.1016/j.bbapap.2010.12.012. Epub 2011 Jan 4.

PMID:
21215335
21.

Systemic diseases: from amyloidosis to cryoglobulinemia.

Grünfeld JP.

Clin J Am Soc Nephrol. 2010 Nov;5(11):1912-5. doi: 10.2215/CJN.08130910. Epub 2010 Oct 14. No abstract available.

22.

Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis.

Kastritis E, Wechalekar AD, Dimopoulos MA, Merlini G, Hawkins PN, Perfetti V, Gillmore JD, Palladini G.

J Clin Oncol. 2010 Feb 20;28(6):1031-7. doi: 10.1200/JCO.2009.23.8220. Epub 2010 Jan 19.

PMID:
20085941
23.

AL amyloidosis associated with IgM monoclonal protein: a distinct clinical entity.

Palladini G, Russo P, Bosoni T, Sarais G, Lavatelli F, Foli A, Bragotti LZ, Perfetti V, Obici L, Bergesio F, Albertini R, Moratti R, Merlini G.

Clin Lymphoma Myeloma. 2009 Mar;9(1):80-3. doi: 10.3816/CLM.2009.n.021.

PMID:
19362981
24.

Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs.

Gobbi PG, Valentino F, Lambelet P, Perfetti V, Bergamaschi G, Girino M, Corazza GR.

Bone Marrow Transplant. 2009 Jul;44(1):19-25. doi: 10.1038/bmt.2008.421. Epub 2009 Jan 12.

PMID:
19139733
25.

Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy.

Gobbi PG, Corbella F, Valentino F, Bergonzi M, Sangalli C, Perfetti V, Corazza GR.

Ann Oncol. 2009 Mar;20(3):465-8. doi: 10.1093/annonc/mdn668. Epub 2008 Dec 11.

26.

Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide.

Palladini G, Russo P, Lavatelli F, Nuvolone M, Albertini R, Bosoni T, Perfetti V, Obici L, Perlini S, Moratti R, Merlini G.

Ann Hematol. 2009 Apr;88(4):347-50. doi: 10.1007/s00277-008-0600-y. Epub 2008 Sep 9.

PMID:
18779964
27.

Sjögren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity?

Meijer JM, Schonland SO, Palladini G, Merlini G, Hegenbart U, Ciocca O, Perfetti V, Leijsma MK, Bootsma H, Hazenberg BP.

Arthritis Rheum. 2008 Jul;58(7):1992-9. doi: 10.1002/art.23617.

28.

Constitutive expression of IL-12R beta 2 on human multiple myeloma cells delineates a novel therapeutic target.

Airoldi I, Cocco C, Giuliani N, Ferrarini M, Colla S, Ognio E, Taverniti G, Di Carlo E, Cutrona G, Perfetti V, Rizzoli V, Ribatti D, Pistoia V.

Blood. 2008 Aug 1;112(3):750-9. doi: 10.1182/blood-2008-02-139378. Epub 2008 May 12.

29.

Paraneoplastic Cushing's syndrome and nephrotic syndrome in a patient with disseminated small cell lung cancer.

Guabello G, Brunetti L, Palladini G, Musumeci S, Lovati E, Perfetti V.

Am J Clin Oncol. 2008 Feb;31(1):102-3. doi: 10.1097/01.coc.0000203741.06225.8a. No abstract available.

PMID:
18376237
30.

Juxtapapillary pancreatic metastasis with obstructive jaundice as isolated recurrence of lung adenocarcinoma.

Perfetti V, Markopoulos K, Maffè GC, Picheo R, Corazza GR.

Dig Liver Dis. 2008 Mar;40(3):230-1. Epub 2007 Dec 21. No abstract available.

PMID:
18096449
31.

Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins.

Navazza V, Gabba S, Alfieri A, Giorgetti S, Marchese L, Palladini G, Mattevi A, Ascari E, Caporali R, Montecucco C, Merlini G, Perfetti V.

Mol Immunol. 2008 Mar;45(5):1519-24. Epub 2007 Oct 18.

PMID:
17949814
32.

Vascular endothelial growth factor promoted endothelial progenitor cell mobilization into the peripheral blood of a patient with POEMS syndrome.

Rosti V, Massa M, Campanelli R, De Amici M, Piccolo G, Perfetti V.

Haematologica. 2007 Sep;92(9):1291-2.

33.

Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis.

Palladini G, Russo P, Nuvolone M, Lavatelli F, Perfetti V, Obici L, Merlini G.

Blood. 2007 Jul 15;110(2):787-8. No abstract available.

PMID:
17606766
34.

Bortezomib-induced paralytic ileus is a potential gastrointestinal side effect of this first-in-class anticancer proteasome inhibitor.

Perfetti V, Palladini G, Brunetti L, Sgarella A, Brugnatelli S, Gobbi PG, Corazza GR.

Eur J Gastroenterol Hepatol. 2007 Jul;19(7):599-601.

PMID:
17556909
35.

Treating ETTCL: A matter of early diagnosis and chemotherapy strategies.

Ciccocioppo R, Perfetti V, Corazza GR.

Dig Liver Dis. 2007 Jul;39(7):642-5. Epub 2007 May 24. No abstract available.

PMID:
17531553
36.

The workings of the amyloid diseases.

Bellotti V, Nuvolone M, Giorgetti S, Obici L, Palladini G, Russo P, Lavatelli F, Perfetti V, Merlini G.

Ann Med. 2007;39(3):200-7. Review.

PMID:
17457717
37.

Development of a Richter syndrome with a monoclonal component from a true B-cell chronic lymphocytic leukemia (B-CLL) treated with fludarabine.

Bernasconi P, Paulli M, Orlandi E, Perfetti V, Giardini I, Zibellini S, Vanelli L, Tenore AM, Algarotti A, Boni M, De Amici M, Brusamolino E, Lazzarino M.

Ann Hematol. 2007 Aug;86(8):619-22. Epub 2007 Mar 14. No abstract available.

PMID:
17356849
38.

Therapy and management of systemic AL (primary) amyloidosis.

Palladini G, Perfetti V, Merlini G.

Swiss Med Wkly. 2006 Nov 11;136(45-46):715-20. Review.

PMID:
17183435
39.

Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis.

Perfetti V, Siena S, Palladini G, Bregni M, Di Nicola M, Obici L, Magni M, Brunetti L, Gianni AM, Merlini G.

Haematologica. 2006 Dec;91(12):1635-43.

41.

Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL.

Palladini G, Lavatelli F, Russo P, Perlini S, Perfetti V, Bosoni T, Obici L, Bradwell AR, D'Eril GM, Fogari R, Moratti R, Merlini G.

Blood. 2006 May 15;107(10):3854-8. Epub 2006 Jan 24.

42.

Pharmacokinetic behavior of rituximab: a study of different schedules of administration for heterogeneous clinical settings.

Regazzi MB, Iacona I, Avanzini MA, Arcaini L, Merlini G, Perfetti V, Zaja F, Montagna M, Morra E, Lazzarino M.

Ther Drug Monit. 2005 Dec;27(6):785-92.

PMID:
16306856
43.

Clinical aspects of systemic amyloid diseases.

Obici L, Perfetti V, Palladini G, Moratti R, Merlini G.

Biochim Biophys Acta. 2005 Nov 10;1753(1):11-22. Epub 2005 Sep 2. Review.

PMID:
16198646
44.

The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL).

Palladini G, Perfetti V, Perlini S, Obici L, Lavatelli F, Caccialanza R, Invernizzi R, Comotti B, Merlini G.

Blood. 2005 Apr 1;105(7):2949-51. Epub 2004 Nov 30.

PMID:
15572585
45.

Insights into the regulation of immunoglobulin light chain gene rearrangements via analysis of the kappa light chain locus in lambda myeloma.

Perfetti V, Vignarelli MC, Palladini G, Navazza V, Giachino C, Merlini G.

Immunology. 2004 Jul;112(3):420-7.

46.

Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families.

Obici L, Palladini G, Giorgetti S, Bellotti V, Gregorini G, Arbustini E, Verga L, Marciano S, Donadei S, Perfetti V, Calabresi L, Bergonzi C, Scolari F, Merlini G.

Gastroenterology. 2004 May;126(5):1416-22.

PMID:
15131802
47.

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation.

Palladini G, Perfetti V, Obici L, Caccialanza R, Semino A, Adami F, Cavallero G, Rustichelli R, Virga G, Merlini G.

Blood. 2004 Apr 15;103(8):2936-8. Epub 2003 Dec 18.

PMID:
15070667
48.

PAS positive monocytes in Whipple s disease.

Invernizzi R, Travaglino E, Perfetti V.

Haematologica. 2003 Dec;88(12):EIM16. No abstract available.

49.

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Palladini G, Campana C, Klersy C, Balduini A, Vadacca G, Perfetti V, Perlini S, Obici L, Ascari E, d'Eril GM, Moratti R, Merlini G.

Circulation. 2003 May 20;107(19):2440-5. Epub 2003 Apr 28.

50.

Clinical and molecular remission following reduced intensity conditioning and allogeneic transplantation in a patient with refractory multiple myeloma.

Dodero A, Perfetti V, Ciceri F, Corradini P.

Haematologica. 2002 Dec;87(12):ECR41. No abstract available.

PMID:
12495912

Supplemental Content

Loading ...
Support Center